The Association of Health Care Journalists strongly urges the U.S. Department of Health and Human Services to keep public all data related to COVID-19 hospitalizations and to post the numbers as soon as they are available.
The Trump administration ordered hospitals to stop reporting COVID-19 data to the Centers for Disease Control and Prevention and send patient information to a central database in Washington, D.C., starting this week.
The House recently passed a health reform bill – and it’s a definite win for the incrementalists.
The Democratic presidential primaries – which now feel like they took place in another universe, long ago and far away – were animated by a significant divide over whether to move to a single-payer “Medicare for All” health care system or to build upon the Affordable Care Act. Presumptive Democratic nominee Joe Biden wants to build on the ACA and favors adding a public option. Continue reading →
Cheryl Clark (@CherClarHealth) is AHCJ's core topic leader for patient safety, a MedPage Today contributor and inewsource.org investigative journalist. For most of 27 years, she covered medicine and science for the San Diego Union-Tribune. After taking a buyout in 2008, she became senior quality editor for HealthLeaders Media.
As you write about the continuing back and forth over the how and when — and if — it will be safe to reopen schools for on-site classes next month, journalists might ask these questions:
What do case counts in children and teens look like in your area?
Are they growing every day?
If so, how fast?
Are the children symptomatic?
And are their teachers, administrators, family members and friends getting sick?
In California, for example, case counts among those 17 and younger have been climbing, from 1.3% of the state’s case counts on April 7 (222) to 3.4% on May 7 (2,181) to 8.3% as of Saturday (July 11), (26,652). Continue reading →
Liz Seegert (@lseegert), is AHCJ’s topic editor on aging. Her work has appeared in NextAvenue.com, Journal of Active Aging, Cancer Today, Kaiser Health News, the Connecticut Health I-Team and other outlets. She is a senior fellow at the Center for Health Policy and Media Engagement at George Washington University and co-produces the HealthCetera podcast.
Could an Alzheimer’s drug finally be on the horizon? Possibly ― if the FDA agrees with data from several Biogen clinical trials ― but approval is still far from a sure bet.
The company, on July 9, submitted its biologics license application (BLA) for aducanumab, an investigational treatment for the disease. The submission includes clinical data from Phase 3 EMERGE and ENGAGE studies, as well as the Phase 1B PRIME study. Biogen has requested an accelerated review, potentially putting the medication on a path for a final decision by March 2021. However, data from these Phase 3 trials are not without controversy in the scientific community.
“Aducanumab, a so-called monoclonal antibody designed to target amyloid plaque in the brain, has been one of the most closely watched drugs in development for several years,” according to Bloomberg News. Continue reading →
Source: Catalyst for Payment Reform and the Source on Healthcare Price and Competition, Report Card on State Price Transparency Laws, May 2020.The Report Card on State Price Transparency Laws shows 34 states got failing grades and only two states got A grades (Maine and New Hampshire).
A federal judge last month ruled against the American Hospital Association and other hospital groups in their lawsuit against the Trump administration’s plan to require hospitals to publish the prices they charge consumers.
Tara Haelle (@TaraHaelle) is AHCJ's medical studies core topic leader, guiding journalists through the jargon-filled shorthand of science and research and enabling them to translate the evidence into accurate information.
Of all the skills needed for reporting on medical research, it’s hard to think of one more important than being able to read and understand a single medical study. That may sound obvious, but a surprising number of journalists find their way to covering research findings before they have learned how to read the research papers themselves. (I once was one of them!)
I usually give a talk reviewing the basics of this task at the AHCJ conference each year, but this year’s conference unfortunately was among the large meeting casualties of the pandemic. Regardless, learning to read scientific studies is one of those skills where you get better at it the more you try to do it yourself and the more you hear from different people about how they do it. Continue reading →